Has Joann Streb received payments from drug or device companies?

Yes. Drug and device makers reported $6,716 in general payments to Joann Streb across 161 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Joann Streb did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Joann Streb come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Joann Streb

Psychiatric/Mental Health · Rochester, NYNPI 1790906238

Payments from drug & device makers

$6,716in general payments, 2019–2025

Across 161 payments — averaging $41.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$3K
Vanda Pharmaceuticals Inc.$829
Otsuka America Pharmaceutical, Inc.$651
AbbVie$578
Alkermes, Inc.$412
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$412
plus $1K from 8 others

What the payments were for

Food & beverage$6,716100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	38	$2,575
Vanda Pharmaceuticals Inc.	26	$829
Otsuka America Pharmaceutical, Inc.	10	$651
AbbVie	28	$578
Alkermes, Inc.	9	$412
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	8	$412
Lundbeck LLC	12	$358
Teva Pharmaceuticals USA, Inc.	13	$324
Neurocrine Biosciences, Inc.	8	$259
E.r. Squibb & Sons, L.L.C.	1	$125
Indivior Inc.	3	$83
Axsome Therapeutics, Inc.	3	$56
Corium, LLC	1	$32
Avanir Pharmaceuticals, Inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,716 in reported general payments places this provider in the 95th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Austedo XrDeutetrabenazine	42	$312,312
VraylarCariprazine Hcl	33	$48,255
Abilify MaintenaAripiprazole	14	$41,259
Lurasidone Hcl	31	$4,192
Clozapine	52	$2,528
Quetiapine Fumarate	158	$2,513
Paliperidone ErPaliperidone	16	$2,467
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	22	$2,023
Aripiprazole	46	$1,720
Bupropion XlBupropion Hcl	103	$1,632
Hydroxyzine Hcl	77	$1,627
Ziprasidone Hcl	11	$1,559
Olanzapine	86	$1,192
Gabapentin	51	$1,170
Divalproex Sodium ErDivalproex Sodium	34	$1,040

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr	$324	$312,31242 claims
AbbVieVraylar	$578	$48,25533 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena	$651	$41,25914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Rochester

Glenn HannDansville$1.3M
Tammy RussoNiskayuna$568K
Carrie EdickSchenectady$484K
Eric SpronzCentereach$448K
Terry Jo Brooks-DevlinTonawanda$176K
Kevin SiewersStaten Island$155K
Daniel BreeyearNiskayuna$149K
Mary OlsonNew York$142K
Elijah StevensBinghamton$131K
Kayanna JonasFar Rockaway$93K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →